USFDA pulls up Eugia for manufacturing lapses at its Telangana plant ...Middle East

Business Standard - Economy
USFDA pulls up Eugia for manufacturing lapses at its Telangana plant
The US health regulator has pulled up Aurobindo Pharma's subsidiary Eugia for manufacturing lapses at its Telangana-based plant. In a warning letter to Eugia Pharma Specialities CEO Yugandhar Puvvala, the US Food and Drug Administration (USFDA) pointed out that the company failed to ensure the accuracy of data for production and process simulation. "Your firm failed to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards," USFDA stated. The US health regulator said it inspected the Patancheru (Mandal), Sangareddy, Hyderabad-based plant from January 22 to February 2, 2024. "You failed to ensur

Hence then, the article about usfda pulls up eugia for manufacturing lapses at its telangana plant was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( USFDA pulls up Eugia for manufacturing lapses at its Telangana plant )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 2 hours & 53 minute
before 11 hour & 3 minute